Departing NIH Director Monica Bertagnolli looks back at a whirlwind tenure
The biomedical research agency’s 17th director is proud of her initiatives amid tough political landscape
The biomedical research agency’s 17th director is proud of her initiatives amid tough political landscape
Two compounds prolonged the survival of photoreceptors in a retinitis pigmentosa mouse model for rod opsin misfolding
A historian confronts the complicated origins and uncertain future of priming research
Obesity disrupts cholesterol homeostasis to inhibit the accumulation of insulin-sensitizing ST2hi VAT Treg subsets.
The medical imaging community has started to give its verdict on the U.K. government’s 26-page strategy document for AI that was unveiled on 13 January.
Billed as more than 10 times the scale of previous endeavors, the Truveta Genome Project aims to ensure representation across ancestries, ethnicities, genders and other…
Post-acute care organizations face the same threats as their larger counterparts when it comes to combating cybersecurity attacks. They are often under-resourced and lack funding,…
Billed as more than 10 times the scale of previous endeavors, the Truveta Genome Project aims to ensure representation across ancestries, ethnicities, genders and other…
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing giant’s Illumina Connected Analytics (ICA) platform.
Shez Partovi, chief innovation and strategy officer at Philips, discussed the helium-free BlueSeal MRI and AI advances in a sit down with MobiHealthNews at JPM.